[PDF][PDF] 厄洛替尼治疗老年晚期非小细胞肺癌的临床观察
杨燕霞， 毋永娟， 华云旗， 袁海清 - 2009 - scholar.archive.org
… the side effects of erlotinib in the treatment of elderly patients … non-small cell lung cancer
were treated with erlotinib 150 mg/d, … for efficacy of epidermal growth factor receptor inhibitors in …
were treated with erlotinib 150 mg/d, … for efficacy of epidermal growth factor receptor inhibitors in …
[HTML][HTML] 免疫环境因子IEF 在EGFR-TKIs 治疗的EGFR 突变阳性晚期非小细胞肺癌中预后价值研究
杨雪， 刘根利， 李玲， 吴大鹏， 王笑荷… - Advances in Clinical …, 2021 - hanspub.org
… factors in serum for the prognosis of EGFR mutations positive non-small cell lung cancer (NSCLC)
treated with epidermal growth factor … NSCLC who were treated with erlotinib, gefitinib …
treated with epidermal growth factor … NSCLC who were treated with erlotinib, gefitinib …
[HTML][HTML] 盐酸埃克替尼治疗EGFR 突变状态明确的晚期非小细胞肺癌的临床观察
李曦， 秦娜， 王敬慧， 杨新杰， 张新勇… - Chinese Journal of …, 2015 - ncbi.nlm.nih.gov
… epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, gefitinib and erlotinib,
icotinib … To explore the efficacy and side effects of icotinib hydrochloride in the treatment of the …
icotinib … To explore the efficacy and side effects of icotinib hydrochloride in the treatment of the …
[HTML][HTML] 厄洛替尼治疗脑脊液检测EGFR 敏感突变的肺腺癌一例
李晓燕， 杨辉， 许华艳， 王沙沙… - Chinese Journal of Lung …, 2016 - ncbi.nlm.nih.gov
… treatment of brain metastasis was radiotheraphy including whole brain irradiation (WBI) and
stereotactic radiotherapy (SRT). It has been reported that epidermal growth factor … erlotinib. …
stereotactic radiotherapy (SRT). It has been reported that epidermal growth factor … erlotinib. …
[PDF][PDF] 表皮生长因子受体抑制剂致相关皮肤瘙痒的机制研究
彭艳梅， 刘青， 邓博， 崔慧娟， 段桦… - 中国比较医学 …, 2018 - zgbjyx.cnjournals.com
… the epidermal growth factor receptor inhibitor (EGFRI)⁃erlotinib … groups of mice were treated
with erlotinib or SP to induce … induced by erlotinib appeared2 to 5 days after treatment. In …
with erlotinib or SP to induce … induced by erlotinib appeared2 to 5 days after treatment. In …
[HTML][HTML] 吉非替尼治疗32 例肺腺癌脑转移的临床经验
许建萍， 刘潇衍， 杨晟， 张湘茹… - Chinese Journal of Lung …, 2015 - ncbi.nlm.nih.gov
… Gefitinib was an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor which
has been used in the treatment of NSCLC. Our study was to evaluate the efficacy and toxicities …
has been used in the treatment of NSCLC. Our study was to evaluate the efficacy and toxicities …
[HTML][HTML] 大肠癌细胞FoxQ1 与EGFR 基因表达的相关性
白璇， 唐慧， 郭强 - 肿瘤防治研究, 2016 - zlfzyj.com
… Abstract:Objective To discuss the relationship between FoxQ1 and epidermal growth factor
… relative expression in DLD1 cells treated with different concentrations of Erlotinib HCl …
… relative expression in DLD1 cells treated with different concentrations of Erlotinib HCl …
[HTML][HTML] 非小细胞肺癌分子靶向EGFR-TKI 治疗敏感性与治疗耐受性预测筛选的分子显像研究现状及进展
戴东， 徐文贵， 王琦， 李小凤， 朱研佳 - Chinese Journal of Lung …, 2017 - ncbi.nlm.nih.gov
… guide the therapy before treatment and treatment of sensitive … 生长因子受体（epidermal growth
factor receptor, EGFR）介导的… Memon研究结果 [41] 表明， 11 C-erlotinib能够在erlotinib高度…
factor receptor, EGFR）介导的… Memon研究结果 [41] 表明， 11 C-erlotinib能够在erlotinib高度…
[HTML][HTML] MET 14 外显子跳跃突变在非小细胞肺癌中的研究进展
尹利梅， 卢铀 - Chinese Journal of Lung Cancer, 2018 - ncbi.nlm.nih.gov
… has achieved great success in the treatment of non-small cell … for NSCLC since epidermal
growth factor receptor (EGFR) and … 该患者的治疗方案变成Erlotinib（100 mg/d）联合卡博替尼（60 …
growth factor receptor (EGFR) and … 该患者的治疗方案变成Erlotinib（100 mg/d）联合卡博替尼（60 …
[PDF][PDF] 艾迪注射液联合厄洛替尼对晚期非小细胞肺癌患者T 淋巴细胞, 血管内皮生长因子和生活质量的影响
王菲， 李松 - 世界临床药物, 2020 - jwph.com.cn
… combined with erlotinib on T lymphocytes, vascular endothelial growth factor(VEGF), …
erlotinib in the treatment of advanced NSCLC can effectively reduce the level of angiogenic factors …
erlotinib in the treatment of advanced NSCLC can effectively reduce the level of angiogenic factors …